New brief therapy aims to help veterans in opioid recovery find purpose

NCT ID NCT05189223

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing a short, values-based therapy for Veterans who have recently started medication for opioid use disorder (like buprenorphine). The therapy focuses on helping them clarify their personal values, set goals, and improve social connections. The study has three phases: first, developing the therapy with input from Veterans and providers; second, testing it with 10 Veterans; and third, comparing it to usual care in a pilot trial with 40 Veterans. The goal is to see if this approach is feasible and acceptable, and whether it can improve quality of life and social functioning during early recovery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
brief values-based behavioral intervention
What this could lead to
If it works, this could provide a practical, short-term therapy to help Veterans in early opioid treatment rebuild their social lives and sense of purpose.
What could go wrong
This is a very small, early-phase pilot study (50 participants total) testing feasibility and acceptability, not effectiveness. The intervention is brief and may not produce lasting changes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEPENDENCE, OPIOID are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • VA Bedford HealthCare System, Bedford, MA

    RECRUITING

    Bedford, Massachusetts, 01730-1114, United States